Recombinant human monoclonal antibody against tetanus toxin(Lanzhou Institute Of Biological )

重组人源抗破伤风毒素单克隆抗体（兰州生物制品）

Report date: 2024/07/15 17:41:24

Base Information

Drug NameRecombinant human monoclonal antibody against tetanus toxin(Lanzhou Institute Of Biological )
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTetanus toxin inhibitors
TargetsTetanus toxin
Therapy Area/IndicationsTetanus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A